How to Buy Akebia Therapeutics Stock
Akebia Therapeutics Inc
Akebia Therapeutics, Inc. , a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases.
Akebia Therapeutics stock last closed at $1.54, down 3.14% from the previous day, and has decreased 23.76% in one year. It has overperformed other stocks in the Biotechnology industry by 0.23 percentage points. Akebia Therapeutics stock is currently +6.57% from its 52-week low of $1.45, and -62.25% from its 52-week high of $4.08.
At the moment, there are 265.37M AKBA shares outstanding. The market cap of AKBA is $408.66M. In the last 24 hours, 2.2M AKBA shares were traded.
How to Buy Akebia Therapeutics Stock
Wondering how to invest in Akebia Therapeutics stock? Here's how.
- Decide where to buy Akebia Therapeutics stock: You need to decide on an online brokerage, but don't worry - we've analyzed dozens of stock brokerages and apps to help you decide where to buy Akebia Therapeutics stock.
- Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Deposit funds into your investment account: Choose your payment method and add your information.
- Evaluate Akebia Therapeutics stock: The Akebia Therapeutics ticker symbol is AKBA. Is Akebia Therapeutics stock a good investment? Should you buy shares of AKBA? How do AKBA's underlying business fundamentals look? Do top analysts think Akebia Therapeutics is a good buy? Why has AKBA's stock price moved recently? (Hint: Our stock research website can help you evaluate if AKBA is a good stock to buy).
- Make your AKBA buy order: Decide if you will purchase AKBA shares at the current market price or use a limit order to buy AKBA stock at a particular price.
- Keep tabs on your AKBA position: Create a watchlist to key updates about your new investment in Akebia Therapeutics stock.
Step 1: Decide where to buy Akebia Therapeutics stock
You will need an online brokerage account in order to access the NASDAQ market and buy AKBA shares.
Our favorite brokerage: eToro
In our opinion, eToro is the best online stock brokerage. Here's why:
- Invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to global financial markets: From Tech to Healthcare, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top exchanges.
- Social investing: eToro boasts a community with more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Create your brokerage account
Now that you've selected the best brokerage, you'll need to fill out some personal details so you are able to invest in AKBA today.
How to Start a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal data to create your new brokerage account.
- Send your details by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your investment account
Now that you've created your account on the best stock trading app, you need to deposit funds:
Check out this video walkthrough if you need help depositing funds into your new brokerage account.
Step 4: Evaluate Akebia Therapeutics stock
After you have figured out the best place to buy Akebia Therapeutics stock, it's crucial to evaluate their stock before you invest, so you truly wrap your head around the risk as well as the upside.
Akebia Therapeutics Numbers
Akebia Therapeutics Overview
WallStreetZen was designed to help part-time investors do more accurate fundamental analysis quickly.
You can view all of the due diligence checks on AKBA's stock page.
Is AKBA stock overvalued?
Investors use many financial metrics, analyses, models, and charts to gauge AKBA's intrinsic value.
Using relative valuations methods:
- AKBA may be overvalued based on its P/B ratio of 9.83x, relative to Biotechnology industry P/B ratio of 5.29x
You can access additional valuation research on AKBA's stock here.
AKBA Financial Health Overview
Pros:
- AKBA profit margin has gone up from -27.1% to -7.1% in the past year.
- There are more short-term assets than short-term liabilities on the AKBA balance sheet.
- AKBA's operating cash flow of $32.40M allows it to safely service it's debt of $47.64M.
- There are more short-term assets than long-term liabilities on the AKBA balance sheet.
Cons:
- AKBA earnings of $10.94M is not sufficient to cover its interest payments.
- Total AKBA debt is higher than 5 years ago, relative to shareholder equity.
- AKBA has a relatively high debt to equity ratio of 7.76.
Is it a good time to buy AKBA stock, according to Wall Street analysts?
Out of 2 sell side analysts who research AKBA, the consensus analyst rating on AKBA is a Strong Buy
Please note that analyst forecasts are not stock recommendations, nor are they financial advice.
You can dive deeper into what analysts are projecting on the Akebia Therapeutics stock forecast page.
Metrics for Advanced AKBA Traders
Is AKBA Growing Revenue?
Last year, AKBA revenue was $225.07M. During the past 5 year, AKBA's revenue has increased by -6.09% per year. This was slower than the Biotechnology industry average of 44.12%.
Dive into AKBA's earnings and revenue performance here.
What are AKBA insiders up to?
Over the past 12 months, executives and large shareholders at AKBA have sold more shares than they have bought.
Erik Ostrowski, SVP CFO CBO Treasurer of AKBA, was the latest AKBA insider to sell. They sold $151,622.38 worth of AKBA shares on Jun 30, 2025.
Dig into more about who owns AKBA shares here.
Does AKBA provide a stable income stream?
No, Akebia Therapeutics doesn't provide an income stream by paying out dividends.
Get analysis from other traders
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Make your AKBA buy order
You have two main options:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are generally fine for most investors. - Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
If you want to ensure you're buying or selling at an exact dollar amount limit, use a limit order.
Click the Open button and your broker will place your order.
If you need more help investing in stocks on eToro, watch the how to video below:
Step 6: Keep tabs on your AKBA position
Now that you own some shares in AKBA, you'll want to keep up with your shares.
Put AKBA on a watchlist to track the latest developments regarding your AKBA stock.
AKBA Feed
How to Buy Stock in Akebia Therapeutics
To summarize, here are the 6 steps to buy stock in Akebia Therapeutics:
- Decide where to buy Akebia Therapeutics stock
- Create your brokerage account
- Deposit funds into your investment account
- Evaluate Akebia Therapeutics stock
- Make your AKBA buy order
- Keep tabs on your AKBA position
If you are looking for a online brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to track your new investment in Akebia Therapeutics, add AKBA to your watchlist by clicking the button below.
Trending Articles
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.